Navigation Links
Amgen Presents New XGEVA™ (Denosumab) Breast Cancer Skeletal-Related Event Prevention Data at SABCS
Date:12/10/2010

EVA patients (3.5 percent fewer [range: -1.1 percent to 11.5 percent fewer]) than Zometa treated patients had a meaningful decrease in health-related quality of life over the 18 months.  

Interim Results Demonstrate Skeletal-Related Events in Breast Cancer Patients are Associated with Considerable Health Resource Utilization (Abstract Number: P1-13-06)SREs have an adverse financial impact on healthcare systems, consuming significant resources. The first interim results from the breast cancer section (n=67) of an ongoing study assessing the health resource utilization per type of SRE (119 discreet SREs) found that pathologic fracture required the longest hospital stay (19 days, n=18), with spinal cord compression requiring the second most days (13.3 days, n=5). Additionally, radiation to bone required the most procedures (14.7, n=87), such as imaging, followed by spinal cord compression (10.4, n=5).

This section of an ongoing observational, multinational study assessed SRE-related utilization of health resources by SRE type (surgery or radiation to bone, pathologic fracture, or spinal cord compression) in breast patients with bone metastases. Data was collected on inpatient hospitalizations, length of stay, outpatient visits, emergency room (ER) visits, nursing home/long-term care facility stays, home health visits, procedures, and medications.

Acute Phase Reactions Following Treatment with Zometa or XGEVA (Abstract Number: P6-14-09) An analysis of the Phase 3 "136" data compared the potential for acute phase reactions following treatment with either Zometa or XGEVA. Results of this analysis will be presented Sunday, Dec. 12 at 7:00 a.m. CT.

About the XGEVA Phase 3 Breast Cancer SRE Prevention Study "136" Study "136" is an international, Phase 3, randomized, double-blind study comparing XGEVA with Zometa in the treatment of bone metastases in patients with advanced breast cancer to prevent SREs. Patients enrolled in the st
'/>"/>

SOURCE Amgen
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine technology :

1. Amgen to Present at Deutsche Banks 2010 BioFEST
2. Amgen Highlights Data to Be Presented at American Society of Hematology Annual Meeting
3. Amgen Foundation and Ashokas Changemakers Announce Finalists in Patients
4. Choices
5. Empowerment Competition
6. Amgen, Pfizer, and World-Class Professional Golfer Phil Mickelson Announce Partnership
7. Amgen Foundation Awards $4.5 Million Grant to MLA Partner Schools to Invest in LAs Promise
8. Amgen’s Third Quarter 2010 Revenue Unchanged at $3.8 Billion Versus Prior Year
9. Amgen Announces Webcast of 2010 Third Quarter Financial Results
10. Amgen to Review Results From TREAT and Propose Updates to ESA Labeling for Chronic Renal Failure Patients at an FDA Advisory Committee Meeting Today
11. Amgen Highlights Key Clinical Data to be Presented at European Society for Medical Oncology Congress
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)... May 4, 2015  CytRx Corporation (Nasdaq: ... specializing in oncology, today announced an interim analysis ... studies pairing aldoxorubicin with either gemcitabine or ifosfamide. ... ifosfamide with escalating doses of aldoxorubicin. The combinations ... the lowest dose level of aldoxorubicin (170 mg/m2), ...
(Date:5/4/2015)... YORK , May 4, 2015  FireflySci Inc., the newest member of the cuvette ... after launch, they have turned the cuvette industry on its head by offering scientists amazing support ... http://photos.prnewswire.com/prnh/20150501/213243LOGO Photo - http://photos.prnewswire.com/prnh/20150501/213244 ... ... ...
(Date:5/4/2015)... 4, 2015 The Pharmacy Workforce Center recently ... that pharmacy has shifted toward a female-dominated profession. With ... managers, there is an incredible opportunity for women to ... decade. In a new blog post ... Insights , Eden Sulzer, director of the Women ...
Breaking Medicine Technology:CytRx Reports Aldoxorubicin Demonstrates Both Tumor Shrinkage and Improved Quality of Life in Chemotherapy Resistant Cancers 2CytRx Reports Aldoxorubicin Demonstrates Both Tumor Shrinkage and Improved Quality of Life in Chemotherapy Resistant Cancers 3CytRx Reports Aldoxorubicin Demonstrates Both Tumor Shrinkage and Improved Quality of Life in Chemotherapy Resistant Cancers 4CytRx Reports Aldoxorubicin Demonstrates Both Tumor Shrinkage and Improved Quality of Life in Chemotherapy Resistant Cancers 5CytRx Reports Aldoxorubicin Demonstrates Both Tumor Shrinkage and Improved Quality of Life in Chemotherapy Resistant Cancers 6CytRx Reports Aldoxorubicin Demonstrates Both Tumor Shrinkage and Improved Quality of Life in Chemotherapy Resistant Cancers 7New Cuvette Manufacturer Delivers Fast, Easy Solutions for Even the Hardest Cuvette Experiments 2New Cuvette Manufacturer Delivers Fast, Easy Solutions for Even the Hardest Cuvette Experiments 3Cardinal Health Expert Discusses Latest Research On Gender Gap In Pharmacy 2Cardinal Health Expert Discusses Latest Research On Gender Gap In Pharmacy 3
(Date:5/4/2015)... The University of California, Davis and ... initiative at UC Davis School of Medicine dedicated ... to advancing Latino health. , The program, called ... to Be Physicians, (“Prep Médico” for short) is ... and internship opportunities, a residential program, intensive language ...
(Date:5/4/2015)... Georgia (PRWEB) May 04, 2015 Each year, ... country to raise funds and awareness for breast cancer. This ... Surgery will be featured as the entertainment sponsor for the ... Cure” on May 9 at the Lenox Square Mall. , ... Atlanta race, and to raise $1.2 million. Perimeter Plastic Surgery ...
(Date:5/4/2015)... Johnson & Wales University (JWU) held a groundbreaking ceremony ... on Wednesday, April 22. , Johnson & Wales becomes the ... the re-alignment of Interstate-195. JWU’s new academic building, which will ... in Providence, is scheduled to be completed in July 2016. ... university purchased in 2012. , “It has long been our ...
(Date:5/4/2015)... May 04, 2015 The Lymphoma Research ... exclusively to funding innovative lymphoma research and serving the ... outreach initiatives and patient services – is set to ... Mayfair Farms in West Orange, NJ on June 1, ... for innovative research programs through LRF. , This year, ...
(Date:5/4/2015)... (PRWEB) May 04, 2015 Baptist ... Association/American Stroke Association’s Get With The Guidelines®-Stroke Gold ... Stroke Honor Roll. The award recognizes the hospital’s ... receive the most appropriate treatment according to nationally ... evidence. , To receive the Gold Plus Quality ...
Breaking Medicine News(10 mins):Health News:New UC Davis Program Targets Next Generation of Physicians to Advance Latino Health 2Health News:New UC Davis Program Targets Next Generation of Physicians to Advance Latino Health 3Health News:New UC Davis Program Targets Next Generation of Physicians to Advance Latino Health 4Health News:New UC Davis Program Targets Next Generation of Physicians to Advance Latino Health 5Health News:Perimeter Plastic Surgery Sponsors 2015 Susan G. Komen Greater Atlanta "Race for the Cure" 2Health News:Johnson & Wales University “Breaks Ground” On New $40 Million Engineering and Science Academic Center 2Health News:Johnson & Wales University “Breaks Ground” On New $40 Million Engineering and Science Academic Center 3Health News:Lymphoma Research Foundation Set to Host Annual Ace Lymphoma Luncheon at Mayfair Farms in West Orange, NJ 2Health News:Baptist Medical Center Jacksonville Receives Top Honor for Stroke Care 2Health News:Baptist Medical Center Jacksonville Receives Top Honor for Stroke Care 3Health News:Baptist Medical Center Jacksonville Receives Top Honor for Stroke Care 4
... loss to Argentina in a World Cup match in 1998 ... by 27 per cent. The fact that extreme stress and ... known to almost everyone.However, research carried out at the ... Argentina during the 1998 World Cup has provided further evidence ...
... The number of people suffering from spine problems is on ... disc and spinal canal stenosis. Herniated disc is more common ... spinal canal stenosis is common among// older people. Hitherto, both ... an incision of about 12cms to be made and the ...
... of the main concerns of teenagers heading back to school ... UT Southwestern Medical Center say that stress is one of ... stress produces increased secretion of the hormone androgen //which results ... likely to suffer from acne due to the hormonal changes ...
... new study involving twenty mothers and their full-term infants, ... regular sleep cycle. ,Dr. Sari Goldstein from Tel ... the perinatal // period helps infants coordinate their circadian ... clock that helps humans and other beings adjust to ...
... shown that smoking leads to damage of the protective reflexes ... from flowing back into the hroat and smoking causes damage ... chords if fluid enters the area, a condition known as ... by imaging the relex area before and after cigarettes. The ...
... study on both mice and humans are showing why some people ... that if you eat a fatty meal or snack - a ... cholesterol you absorb is strongly influenced by your genes. Experts know ... high fat diet is bad for you. But little has been ...
Cached Medicine News:
... VersaPulse PowerSuite holmium laser combines excellent ... precise, virtually bloodless procedures. It is ... and gall bladder stones of all ... surgical tool. Because its laser light ...
... VersaPulse PowerSuite holmium laser combines excellent ... precise, virtually bloodless procedures. It is ... and gall bladder stones of all ... surgical tool. Because its laser light ...
... capability to quickly deliver up to 250 ... for powerful single-pulse ablation. This type of ... coldest and cleanest CO2 surgical laser available ... with the independent adjustment of pulse energy ...
... technology has allowed for perfecting mini-invasive endoscopic ... various pathologies with a considerable social impact. ... reducing the post-operatory times and represents a ... in all hospital structures.,DEKAs family of Nd:YAG ...
Medicine Products: